CME Group Inc CME reported better-than-expected earnings for the third quarter.
CME Group reported quarterly revenue of $1.338 billion, slightly missing the consensus of $1.342 billion. Adjusted EPS of $2.25 surpassed the estimate of $2.22.
CME Group shares rose 0.9% to trade at $216.03 on Thursday.
These analysts made changes to their price targets on CME Group following earnings announcement.
- Barclays cut the price target on CME Group from $247 to $244. Barclays analyst Jeremy Campbell maintained an Overweight rating.
- Rosenblatt raised the price target on CME Group from $173 to $180. Rosenblatt analyst Andrew Bond maintained a Sell rating on the stock.
- Morgan Stanley lifted the price target on CME Group from $215 to $220. Morgan Stanley analyst Mike Cyprys maintained an Equal-Weight rating.
Also Check This Out: Kimberly-Clark, Roblox And 2 Other Stocks Insiders Are Selling
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in